Hernando Cubero, J., Teule, A., Lopez, C., Garcia-Carbonero, R., Benavent, M., Landolfi, S., . . . Nuciforo, P. (2023). Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.
Citação norma ChicagoHernando Cubero, Jorge, Alex Teule, C. Lopez, Rocio Garcia-Carbonero, Marta Benavent, Stefania Landolfi, Jaume Capdevila Castillon, e Paolo Nuciforo. Durvalumab Plus Tremelimumab for the Treatment of Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic and Lung Origin. 2023.
Citação norma MLAHernando Cubero, Jorge, et al. Durvalumab Plus Tremelimumab for the Treatment of Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic and Lung Origin. 2023.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.